Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
{{output}}
The worldwide prevalence of non-alcoholic steatohepatitis (NASH) is increasing, causing a significant medical burden, but no approved therapeutics are currently available. NASH drug development requires histological analysis of liver biopsies by expert patholo... ...
